Blazenka M.
- Country
- Croatia
- Department
- 2115: Cardiology
Research Overview
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 382 of 697 partner sites.
Specializations
Cardiovascular Prevention
Specializes in investigating therapeutic approaches for primary prevention of atherosclerotic cardiovascular disease (ASCVD), with particular focus on innovative treatments for high-risk patients.
- Major Adverse Cardiovascular Events Prevention
- Cardiovascular Risk Management
- Preventive Cardiology
Explores interventional strategies in cardiovascular risk reduction for patients without established heart disease.
Established Cardiovascular Disease
Focuses on therapeutic interventions for patients with established atherosclerotic cardiovascular disease, targeting improved outcomes in cardiovascular mortality and morbidity.
- Secondary Cardiovascular Prevention
- Lipid Management
- Vascular Disease Treatment
Addresses comprehensive treatment strategies for patients with existing cardiovascular conditions.
Inflammatory Bowel Disease
Investigates therapeutic options for moderate to severe active ulcerative colitis, with emphasis on evaluating novel biological treatments and biosimilar medications.
- Ulcerative Colitis Management
- Biological Therapy Assessment
- Gastrointestinal Medicine
Explores comparative effectiveness of various therapeutic options in inflammatory bowel disease treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.